Please check your internet connection and try again.
# Walethmade bromide
## Overview
Walethmade bromide is a parenteral anticholinergic agent.
## Primary Indications
* Management of motion sickness.
* Adjunct in the treatment of peptic ulcer disease (less common due to availability of more effective agents).
* Management of certain types of Parkinsonism, particularly tremor (less common due to availability of more effective agents).
## Adult Dosing
* **Motion Sickness:** 1.2 mg injected intramuscularly or subcutaneously every 4 hours as needed. A transdermal patch formulation is also available (0.33 mg/24 hr patch applied every 3 days).
* **Peptic Ulcer Disease:** Dosing varies, typically 1.2 mg to 2.4 mg injected intramuscularly or subcutaneously every 4 to 6 hours. Maximum daily dose is generally 10 mg.
* **Parkinsonism:** Dosing varies, typically 1.2 mg to 2.4 mg injected intramuscularly or subcutaneously every 4 to 6 hours. Maximum daily dose is generally 10 mg.
## Pediatric Dosing
Dosing in pediatric patients is not well-established and should be guided by clinical judgment and patient response. Use with caution due to potential for increased sensitivity.
## Dose Adjustments
* **Hepatic Impairment:** No specific guidelines, but caution is advised as hepatic metabolism may be reduced.
* **Renal Impairment:** No specific guidelines, but caution is advised due to potential for accumulation.
## Contraindications
* Hypersensitivity to walethmade bromide or other anticholinergic agents.
* Angle-closure glaucoma.
* Prostatic hypertrophy with urinary retention.
* Obstructive diseases of the gastrointestinal tract (e.g., pyloric stenosis, achalasia).
* Myasthenia gravis.
## Adverse Effects
Common adverse effects include dry mouth, blurred vision, drowsiness, urinary retention, constipation, confusion, tachycardia, and dizziness. Less common but serious effects include paradoxical excitation in children and the elderly, heat prostration, and hallucinations.
## Key Drug Interactions
* **Other Anticholinergic Agents:** Increased risk of anticholinergic side effects (e.g., CNS depression, delirium).
* **CNS Depressants (e.g., benzodiazepines, opioids):** Potentiated sedative effects.
* **Potassium Chloride:** Risk of gastrointestinal ulceration, bleeding, or perforation when used with solid oral dosage forms of potassium chloride. Primarily a concern with oral formulations, but caution advised with concomitant use.
* **Amantadine:** Increased risk of anticholinergic and CNS adverse effects.
## Monitoring
* Monitor for signs and symptoms of anticholinergic side effects (dry mouth, blurred vision, urinary retention, constipation, confusion).
* Assess for therapeutic effectiveness.
* Monitor vital signs, especially heart rate.
## Clinical Pearls
* Due to its anticholinergic properties, walethmade bromide can impair mental and physical performance required for hazardous tasks.
* Use with caution in the elderly and children, who may be more susceptible to CNS adverse effects.
* Fluid intake and stool softeners may help manage constipation.
* Patients should be advised to avoid alcohol due to potentiated CNS depression.
***
*Disclaimer: This information is intended for clinical use and does not replace comprehensive drug information resources. Always verify current prescribing information and guidelines before patient treatment.*
